Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
Submitted by
admin
on April 2, 2015 - 10:04am
Source:
WSJ Pharmalot
News Tags:
FDA
diabetes
drug ads
Headline:
Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
Do Not Allow Advertisers to Use My Personal information
